These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22142822)

  • 21. Inhibition of periostin gene expression via RNA interference suppressed the proliferation, apoptosis and invasion in U2OS cells.
    Liu C; Huang SJ; Qin ZL
    Chin Med J (Engl); 2010 Dec; 123(24):3677-83. PubMed ID: 22166650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High expression of HER3 is associated with a decreased survival in gastric cancer.
    Hayashi M; Inokuchi M; Takagi Y; Yamada H; Kojima K; Kumagai J; Kawano T; Sugihara K
    Clin Cancer Res; 2008 Dec; 14(23):7843-9. PubMed ID: 19047113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Forskolin increases neuregulin receptors in human Schwann cells without increasing receptor mRNA.
    Fregien NL; White LA; Bunge MB; Wood PM
    Glia; 2005 Jan; 49(1):24-35. PubMed ID: 15390106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropilin-1 is involved in regulation of apoptosis and migration of human colon cancer.
    Ochiumi T; Kitadai Y; Tanaka S; Akagi M; Yoshihara M; Chayama K
    Int J Oncol; 2006 Jul; 29(1):105-16. PubMed ID: 16773190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Berberine inhibits human colon cancer cell migration via AMP-activated protein kinase-mediated downregulation of integrin β1 signaling.
    Park JJ; Seo SM; Kim EJ; Lee YJ; Ko YG; Ha J; Lee M
    Biochem Biophys Res Commun; 2012 Oct; 426(4):461-7. PubMed ID: 22943849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines.
    Momeny M; Saunus JM; Marturana F; McCart Reed AE; Black D; Sala G; Iacobelli S; Holland JD; Yu D; Da Silva L; Simpson PT; Khanna KK; Chenevix-Trench G; Lakhani SR
    Oncotarget; 2015 Feb; 6(6):3932-46. PubMed ID: 25668816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HER3 overexpression and survival in solid tumors: a meta-analysis.
    Ocana A; Vera-Badillo F; Seruga B; Templeton A; Pandiella A; Amir E
    J Natl Cancer Inst; 2013 Feb; 105(4):266-73. PubMed ID: 23221996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HER3 is required for the maintenance of neuregulin-dependent and -independent attributes of malignant progression in prostate cancer cells.
    Soler M; Mancini F; Meca-Cortés O; Sánchez-Cid L; Rubio N; López-Fernández S; Lozano JJ; Blanco J; Fernández PL; Thomson TM
    Int J Cancer; 2009 Dec; 125(11):2565-75. PubMed ID: 19530240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HER3 expression is correlated to distally located and low-grade colon cancer.
    Lédel F; Stenstedt K; Hallström M; Ragnhammar P; Edler D
    Acta Oncol; 2016 Jul; 55(7):875-80. PubMed ID: 26863446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knockdown of biglycan expression by RNA interference inhibits the proliferation and invasion of, and induces apoptosis in, the HCT116 colon cancer cell line.
    Xing X; Gu X; Ma T
    Mol Med Rep; 2015 Nov; 12(5):7538-44. PubMed ID: 26459740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-expression of HER2 and HER3 receptor tyrosine kinases enhances invasion of breast cells via stimulation of interleukin-8 autocrine secretion.
    Aceto N; Duss S; MacDonald G; Meyer DS; Roloff TC; Hynes NE; Bentires-Alj M
    Breast Cancer Res; 2012 Oct; 14(5):R131. PubMed ID: 23062209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms involved in biological behavior changes associated with Angptl4 expression in colon cancer cell lines.
    Huang XF; Han J; Hu XT; He C
    Oncol Rep; 2012 May; 27(5):1541-7. PubMed ID: 22307217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The heregulin/human epidermal growth factor receptor as a new growth factor system in melanoma with multiple ways of deregulation.
    Stove C; Stove V; Derycke L; Van Marck V; Mareel M; Bracke M
    J Invest Dermatol; 2003 Oct; 121(4):802-12. PubMed ID: 14632199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual inhibition of COX-2/5-LOX blocks colon cancer proliferation, migration and invasion in vitro.
    Che XH; Chen CL; Ye XL; Weng GB; Guo XZ; Yu WY; Tao J; Chen YC; Chen X
    Oncol Rep; 2016 Mar; 35(3):1680-8. PubMed ID: 26707712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of RTKN on progression and metastasis of colon cancer in vitro.
    Qu GQ; Lu YM; Liu YF; Liu Y; Chen WX; Liao XH; Kong WM
    Biomed Pharmacother; 2015 Aug; 74():117-23. PubMed ID: 26349972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The severity of neural invasion is associated with shortened survival in colon cancer.
    Liebl F; Demir IE; Rosenberg R; Boldis A; Yildiz E; Kujundzic K; Kehl T; Dischl D; Schuster T; Maak M; Becker K; Langer R; Laschinger M; Friess H; Ceyhan GO
    Clin Cancer Res; 2013 Jan; 19(1):50-61. PubMed ID: 23147996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NRG-1 Stimulates Serum DJ-1 Increase in Breast Cancers.
    Wang Y; Zhang Y; Lu Q; Wang Y; Sun X; Zhang S
    Pathol Oncol Res; 2019 Jan; 25(1):71-79. PubMed ID: 28963699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human gut flora-fermented nondigestible fraction from cooked bean ( Phaseolus vulgaris L.) modifies protein expression associated with apoptosis, cell cycle arrest, and proliferation in human adenocarcinoma colon cancer cells.
    Campos-Vega R; García-Gasca T; Guevara-Gonzalez R; Ramos-Gomez M; Oomah BD; Loarca-Piña G
    J Agric Food Chem; 2012 Dec; 60(51):12443-50. PubMed ID: 23194196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HER3 Is an Actionable Target in Advanced Prostate Cancer.
    Gil V; Miranda S; Riisnaes R; Gurel B; D'Ambrosio M; Vasciaveo A; Crespo M; Ferreira A; Brina D; Troiani M; Sharp A; Sheehan B; Christova R; Seed G; Figueiredo I; Lambros M; Dolling D; Rekowski J; Alajati A; Clarke M; Pereira R; Flohr P; Fowler G; Boysen G; Sumanasuriya S; Bianchini D; Rescigno P; Aversa C; Tunariu N; Guo C; Paschalis A; Bertan C; Buroni L; Ning J; Carreira S; Workman P; Swain A; Califano A; Shen MM; Alimonti A; Neeb A; Welti J; Yuan W; de Bono J;
    Cancer Res; 2021 Dec; 81(24):6207-6218. PubMed ID: 34753775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting and suppression of HER3-positive breast cancer by T lymphocytes expressing a heregulin chimeric antigen receptor.
    Zuo BL; Yan B; Zheng GX; Xi WJ; Zhang X; Yang AG; Jia LT
    Cancer Immunol Immunother; 2018 Mar; 67(3):393-401. PubMed ID: 29127433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.